|
2025
|
Invention
|
Synthetic trna synthetases and cells comprising synthetic molecules for production of polypeptide... |
|
2024
|
Invention
|
Cancer therapy with il-2 peg conjugates. Disclosed herein are methods for treating a cancer in a ... |
|
2023
|
Invention
|
Cancer therapy with il-2 conjugates and chimeric antigen receptor therapies.
Disclosed herein ar... |
|
|
Invention
|
Head and neck cancer combination therapy comprising an il-2 conjugate and cetuximab.
Disclosed h... |
|
|
Invention
|
Lung cancer combination therapy with il-2 conjugates and an anti-pd-1 antibody or antigen-binding... |
|
|
Invention
|
Immuno oncology combination therapy with il-2 conjugates and pembrolizumab.
Disclosed herein are... |
|
|
Invention
|
Methods for selecting subjects and treating cancer with il-2 therapy. Described herein are method... |
|
2022
|
Invention
|
Cancer combination therapy with il-2 conjugates and cetuximab. Disclosed herein are methods for t... |
|
|
Invention
|
Cancer therapy with il-2 conjugates and chimeric antigen receptor therapies. Disclosed herein are... |
|
|
Invention
|
Head and neck cancer combination therapy comprising an il-2 conjugate and pembrolizumab.
Disclos... |
|
|
Invention
|
Head and neck cancer combination therapy comprising an il-2 conjugate and pembrolizumab. Disclose... |
|
|
Invention
|
Head and neck cancer combination therapy comprising an il-2 conjugate and cetuximab. Disclosed he... |
|
|
Invention
|
Interleukin 10 conjugates and uses thereof.
Disclosed herein are interleukin 10 (IL-10) conjugat... |
|
|
Invention
|
Skin cancer combination therapy with il-2 conjugates and cemiplimab. Disclosed herein are methods... |
|
2021
|
Invention
|
Reverse transcription of polynucleotides comprising unnatural nucleotides. Disclosed herein are m... |
|
|
Invention
|
Immuno oncology combination therapy with il-2 conjugates and pembrolizumab. Disclosed herein are ... |
|
|
Invention
|
Immuno oncology therapies with il-2 conjugates. Disclosed herein are methods and uses relating to... |
|
|
Invention
|
Immuno oncology combination therapy with il-2 conjugates and anti-egfr antibodies.
Disclosed her... |
|
|
Invention
|
Immuno oncology combination therapy with il-2 conjugates and anti-egfr antibodies. Disclosed here... |
|
2020
|
Invention
|
Methods of preparing n6-((2-azidoethoxy)carbonyl)lysine. Disclosed herein are methods of preparin... |
|
|
Invention
|
Interleukin 10 conjugates and uses thereof. Disclosed herein are interleukin 10 (IL-10) conjugate... |
|
|
Invention
|
Il-2 conjugates and methods of use to treat autoimmune diseases. Disclosed herein are composition... |
|
|
Invention
|
Il-15 conjugates and uses thereof. Disclosed herein are interleukin (IL)-15 conjugates and use in... |
|
|
Invention
|
Immuno oncology combination therapies with il-2 conjugates. Disclosed herein are compositions, ki... |
|
|
Invention
|
Immuno oncology combination therapies with il-2 conjugates.
Disclosed herein are compositions, k... |
|
|
Invention
|
Il-2 conjugates and methods of use thereof. Disclosed herein are compositions, kits, and methods ... |
|
|
Invention
|
Il-2 conjugates and methods of use thereof.
Disclosed herein are compositions, kits, and methods... |
|
2019
|
Invention
|
Interleukin 10 conjugates and uses thereof. Disclosed herein are interleukin 10 conjugates and us... |
|
|
Invention
|
Il-15 conjugates and uses thereof. Disclosed herein are interleukin (IL) 15 conjugates and use in... |
|
2018
|
Invention
|
Cytokine conjugates for the treatment of proliferative and infectious diseases.
Disclosed herein... |
|
|
Invention
|
Cytokine conjugates for the treatment of proliferative and infectious diseases. Disclosed h... |
|
|
Invention
|
Incorporation of unnatural nucleotides and methods thereof.
Disclosed herein are methods, compos... |
